Source: ERJ Open Res, 5 (2) 00161-2018; 10.1183/23120541.00161-2018
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Sebastian Vencken, Camilla Foged, Joanne M. Ramsey, Louise Sweeney, Sally-Ann Cryan, Ronan J. MacLoughlin, Catherine M. Greene. Nebulised lipid–polymer hybrid nanoparticles for the delivery of a therapeutic anti-inflammatory microRNA to bronchial epithelial cells. ERJ Open Res, 5 (2) 00161-2018; 10.1183/23120541.00161-2018

Member's Comments

No comment yet.

Related content which might interest you: Inhaled solid lipid nanoparticles as a new tool for drug delivery in the lung Source: Annual Congress 2009 - New drugs for airways disease Year: 2009 Inflammatory and antioxidant effects of inhaled nanoparticles on human primary bronchial epithelial cells Source: International Congress 2019 – Involvement of the environment and inflammation in pulmonary remodelling Year: 2019 Engineered nanoparticles induce apoptosis of human bronchial epithelial cells Source: Annual Congress 2011 - Lung cell biology Year: 2011 The antifibrotic effect of Imatinib loaded CD44 targeted gold nanoparticles (Im-CD44-GNP) relies on alveolar macrophage regulation Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside Year: 2018 Bioengineered nanoparticles targeted to mesenchymal cells from patients with BOS exert anti-inflammatory activity Source: International Congress 2017 – The ongoing struggle: insights into chronic lung allograft dysfunction (CLAD) Year: 2017 Novel antiviral properties of azithromycin in cystic fibrosis airway epithelial cells Source: Eur Respir J 2015; 45: 428-439 Year: 2015 Macrophage-derived exosomes attenuate fibrosis in airway epithelial cells through delivery of anti-fibrotic miR-142-3p Source: Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis Year: 2020 The physicochemical properties of nanoparticles determine the mechanism of uptake by human alveolar type I epithelial cells Source: Annual Congress 2010 - Epithelial cells: cell biology and role in lung disease Year: 2010 Pulmonary surfactant as drug delivery system to target lung epithelium: new approach for the treatment of epithelial injury after bleomycin challenge Source: International Congress 2018 – Regenerative and anti-fibrotic approaches Year: 2018 Diesel particle induces aging phenotype of bronchial epithelial cells via disruption of anti-aging molecule Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases Year: 2019 Designed core-shell nanoparticles: intracellular localization and pro-inflammatory cytokine release in lung cells Source: Annual Congress 2009 - Lung cell biology and immunology Year: 2009 Targeting miRNA-based medicines to cystic fibrosis airway epithelial cells using nanotechnology Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung Year: 2012 Effects of functionalised chalcones on pro-inflammatory mediator release from lung epithelial cells Source: Annual Congress 2009 - Inflammatory cells and cytokines Year: 2009 Guaifenesin alters mucus rheology and improves mucociliary transport in human airway epithelial cell cultures: Comparison with N-acetylcysteine and ambroxol Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD Year: 2012 Tiotropium inhibits acetylcholine-induced generation of proinflammatory microparticles by human pulmonary epithelial cells Source: International Congress 2018 – COPD: immune regulation and therapeutic targets Year: 2018 The antiinflammatory effect of statins on human bronchial epithelial cells Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease Year: 2010 The antiinflammatory effect of statins on human bronchial epithelial cells Source: Annual Congress 2008 - Airway cell biology Year: 2008 Intratracheal administration of dry powdered low-molecular-weight chitosan/siRNA complexes suppressed gene expression in the airway and metastatic tumors in murine lung Source: Annual Congress 2012 - New drug targets and pre-clinical models for respiratory diseases Year: 2012 Effect of inhaled surfactant enriched with phosphatidylethanolamine on matrix deposition in a murine model of airway inflammation and remodeling. Source: International Congress 2018 – Basic pharmacology Year: 2018 Aerosolised delivery of mesenchymal stromal cells to the lungs: towards a novel therapy Source: International Congress 2017 – Repair of the emphysematous lung: mesenchymal stromal cell and matrix interactions Year: 2017